| Literature DB >> 16504852 |
Joseph Choukroun1, Antoine Diss, Alain Simonpieri, Marie-Odile Girard, Christian Schoeffler, Steve L Dohan, Anthony J J Dohan, Jaafar Mouhyi, David M Dohan.
Abstract
Platelet-rich fibrin (PRF) belongs to a new generation of platelet concentrates, with simplified processing and without biochemical blood handling. In this fourth article, investigation is made into the previously evaluated biology of PRF with the first established clinical results, to determine the potential fields of application for this biomaterial. The reasoning is structured around 4 fundamental events of cicatrization, namely, angiogenesis, immune control, circulating stem cells trapping, and wound-covering epithelialization. All of the known clinical applications of PRF highlight an accelerated tissue cicatrization due to the development of effective neovascularization, accelerated wound closing with fast cicatricial tissue remodelling, and nearly total absence of infectious events. This initial research therefore makes it possible to plan several future PRF applications, including plastic and bone surgery, provided that the real effects are evaluated both impartially and rigorously.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16504852 DOI： 10.1016/j.tripleo.2005.07.011
Source DB: PubMed Journal: Oral Surg Oral Med Oral Pathol Oral Radiol Endod ISSN： 1079-2104